Mechanistic inhibition of herpes simplex virus-1 UL21 immune-evasion function by natural-product scaffolds: A multi-tier docking, dynamics, and energetic profiling approach
Muhammad Suleman, Imtiaz Ali, Abrar Mohammad Sayaf, Fakhrul Hassan, Usama Ilahi, Mohammed Alissa, Sergio Crovella, Abdullah A Shaito · 2026
Read Mechanistic inhibition of herpes simplex virus-1 UL21 immune-evasion function by natural-product scaffolds: A multi-tier docking, dynamics, and energetic profiling approach by Muhammad Suleman, Imtiaz Ali, Abrar Mohammad Sayaf, Fakhrul Hassan, Usama Ilahi, Mohammed Alissa, Sergio Crovella, Abdullah A Shaito (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0355499.txt.
Description
Muhammad Suleman led a team of eight authors screening natural compounds against herpes simplex virus, published in PLOS ONE in 2026. The virus hides from the immune system with help from a protein called UL21. Blocking that protein's evasion trick could let immunity clear the virus more effectively.
Suleman's team used computer docking, molecular dynamics, and energy calculations in stages to test natural-product scaffolds against UL21. Their pipeline names compounds worth taking into lab tests. Computer screening cannot prove a drug works, but it narrows a huge field to a short list cheaply. For a virus carried by much of the world's population, even early leads toward new antivirals are worth pursuing.
Catalog record
| CREATOR | Muhammad Suleman, Imtiaz Ali, Abrar Mohammad Sayaf, Fakhrul Hassan, Usama Ilahi, Mohammed Alissa, Sergio Crovella, Abdullah A Shaito |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 53538 |
| LICENSE | CC_BY |
| RIGHTS | CC BY |
| SOURCE | PLOS |